Literature DB >> 2106620

Methylated oxypurines and induction of differentiation of murine erythroleukemia cells.

S J Kerr1.   

Abstract

Murine erythroleukemia cell lines derived from Friend virus infected mice can be induced to differentiate in vitro by numerous agents. Among these compounds are certain naturally occurring purines such as hypoxanthine or 1-methylhypoxanthine. We have extended these studies to other modified oxypurines and have identified some areas of cell regulation with which they may be interacting. Monomethylated derivatives of guanine, hypoxanthine or xanthine are active as inducers of differentiation. Excluding hypoxanthine, the parent oxypurines guanine and xanthine are ineffective in inducing differentiation. The dimethyl- and trimethylxanthine derivatives are also inactive as inducers. The methylated oxypurines are not metabolized to nucleotides by the cell and, therefore, probably do not interact with nucleic acid synthesis directly. We have investigated one cellular process of possible regulatory significance with which they do interact. ADP-ribosylation has been implicated in control of gene expression and differentiation. The methylated oxypurines inhibit this reaction, as measured in permeabilized cells, in the same concentration range at which they are effective as inducers of differentiation. Additionally, 1-methylguanine and 7-methylguanine decrease incorporation of mannose and glucosamine into glycoprotein and into dolichol-oligosaccharide precursors. These effects may be related to cell surface alterations observed during differentiation.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2106620     DOI: 10.1007/bf00220717

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  26 in total

1.  Differentiation in erythroleukemic cells and their somatic hybrids.

Authors:  S H Orkin; F I Harosi; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1975-01       Impact factor: 11.205

2.  Inhibition of human purine nucleoside phosphorylase. Studies with intact erythrocytes and the purified enzyme.

Authors:  T A Krenitsky; G B Elion; A M Henderson; G H Hitchings
Journal:  J Biol Chem       Date:  1968-06-10       Impact factor: 5.157

3.  Human hypoxanthine phosphoribosyltransferase. I. Purification, properties, and specificity.

Authors:  T A Krenitsky; R Papaioannou; G B Elion
Journal:  J Biol Chem       Date:  1969-03-10       Impact factor: 5.157

4.  Alterations in cell surface properties induced by modified purines.

Authors:  S J Kerr
Journal:  Tumour Biol       Date:  1985

5.  Induction of erythroid differentiation in vitro by purines and purine analogues.

Authors:  J F Gusella; D Housman
Journal:  Cell       Date:  1976-06       Impact factor: 41.582

6.  Effect of nicotinamide analogues on recovery from DNA damage in C3H10T1/2 cells.

Authors:  E L Jacobson; J Y Smith; M Mingmuang; R Meadows; J L Sims; M K Jacobson
Journal:  Cancer Res       Date:  1984-06       Impact factor: 12.701

7.  Erythroid differentiation and poly(ADP-ribose) synthesis in Friend leukemia cells.

Authors:  K Morioka; K Tanaka; T Nokuo; M Ishizawa; T Ono
Journal:  Gan       Date:  1979-02

8.  Enhancement of the chemical transformation of Chinese hamster embryo cells in vitro by 7-methylguanine.

Authors:  G Muralidhar; R W Trewyn
Journal:  Cancer Res       Date:  1987-05-01       Impact factor: 12.701

9.  Prolonged infusion of hexamethylene bisacetamide: a phase I and pharmacological study.

Authors:  E K Rowinsky; D S Ettinger; W P McGuire; D A Noe; L B Grochow; R C Donehower
Journal:  Cancer Res       Date:  1987-11-01       Impact factor: 12.701

10.  Characterization of the metabolic forms of 6-thioguanine responsible for cytotoxicity and induction of differentiation of HL-60 acute promyelocytic leukemia cells.

Authors:  K Ishiguro; E L Schwartz; A C Sartorelli
Journal:  J Cell Physiol       Date:  1984-11       Impact factor: 6.384

View more
  1 in total

1.  Toxicological Properties of 7-Methylguanine, and Preliminary Data on its Anticancer Activity.

Authors:  Kirill Kirsanov; Timur Fetisov; Elena Antoshina; Lubov Trukhanova; Tatiana Gor'kova; Olga Vlasova; Irina Khitrovo; Ekaterina Lesovaya; Nataliya Kulbachevskaya; Tatiana Shcherbakova; Gennady Belitsky; Marianna Yakubovskaya; Vytas Švedas; Dmitry Nilov
Journal:  Front Pharmacol       Date:  2022-07-06       Impact factor: 5.988

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.